Core Viewpoint - The report from CITIC Securities indicates that due to rising raw material prices and increased demand for AI and storage, a new round of price increases in packaging is expected to begin, with advanced packaging market attention likely to rise driven by domestic computing power demand [1] Group 1: Market Trends - Rising raw material prices are influencing the packaging industry [1] - Increased demand for AI and storage is contributing to market dynamics [1] - The advanced packaging market is expected to gain more attention [1] Group 2: Investment Recommendations - The company suggests focusing on advanced packaging and storage packaging segments for investment opportunities [1]

Core Viewpoint - The liquor industry is expected to enter a peak marketing season during the Spring Festival, with distributors learning from leading companies' multi-dimensional reforms in channels and products [1] Group 1: Market Dynamics - The industry is likely to refocus on market cultivation and consumer education under new reforms and directions, promoting sales and alleviating burdens on distributors [1] - Considering various factors such as stable sales, an additional day off during the 2026 Spring Festival, and consumption scenarios, actual sales of liquor during the 2026 Spring Festival are expected to remain stable, indicating no need for excessive pessimism [1] Group 2: Future Outlook - A gradual recovery trend is anticipated, with a positive outlook on bottom-fishing opportunities in the liquor industry [1] - The beer industry is expected to experience a mild recovery from a bottom position in 2026, with a recommendation to focus on industry leaders that possess strong channel control and brand premium capabilities [1]

Core Viewpoint - The AI wave is expected to widen the power gap, leading to transformative changes in the IDC (Internet Data Center) power systems, with a positive outlook on the market share of domestic server power brands and investment opportunities arising from capacity shortages and product iterations in new products like supercapacitors and SST (Solid State Transformers) [1] Group 1: AI Impact on Power Demand - The demand for power equipment, particularly in North America, is experiencing steep growth driven by AI electricity consumption [1] - The increase in online electricity prices on the supply side presents investment opportunities in SMR (Small Modular Reactors) [1] Group 2: Evolution of Power Systems - The transition of UPS (Uninterruptible Power Supply) towards a fully DC system is underway, with continuous increases in output voltage levels [1] - The rise in power density of server power supplies is expected to lead to simultaneous increases in both product volume and price, potentially driving demand for supercapacitors [1]

Core Viewpoint - Huafeng Measurement and Control announced that CITIC Securities will start market-making services for its stock on the Sci-Tech Innovation Board from January 23, 2026, following the relevant regulations of the Shanghai Stock Exchange [1] Group 1 - Huafeng Measurement and Control's stock code is 688200 [1] - The market-making service will be conducted by CITIC Securities Co., Ltd. [1] - The announcement is in accordance with the implementation rules for market-making trading of Sci-Tech Innovation Board stocks [1]

Core Viewpoint - Puxi Pharmaceutical has submitted its listing application to the Hong Kong Stock Exchange, with CITIC Securities and Minyin Capital acting as joint sponsors [1] Group 1: Company Overview - Puxi Pharmaceutical is a biotechnology company focused on the field of immune inflammation [1] - The company’s product, Pumexitin gel, is a JAK inhibitor gel for the treatment of atopic dermatitis, which has completed Phase III clinical trials for adults and adolescents aged 12 to 17, and is expanding to children aged 2 to 11 [1] - Pumexitin nasal spray is the world's first clinical-stage JAK inhibitor nasal spray for the treatment of seasonal allergic rhinitis, currently in Phase III clinical trials for adults and expanding to adolescents with seasonal allergic rhinitis and adults with perennial allergic rhinitis [1]

Group 1 - The Shanghai Stock Exchange has approved CITIC Securities Co., Ltd. to provide primary market-making services for the Tianhong SSE Sci-Tech Innovation Board Chip Design Thematic Exchange-Traded Fund (referred to as Kexin TH, fund code: 589070) starting from January 23, 2026 [1][2] - This decision aims to enhance the market liquidity and stable operation of the Kexin TH fund [1]

Core Viewpoint - Current valuation levels of the US stock market have significantly converged compared to the extreme levels expected in 2025, with downward adjustments in valuation centers and continuous upward revisions in earnings expectations [1] Group 1: Market Valuation and Earnings Expectations - Since early January, earnings expectations for US stocks in 2026 have been continuously revised upward, with the S&P 500 and Nasdaq 100 expected earnings growth rates at 13.7% and 12.9% respectively [5] - As of January 17, the P/E ratios for the S&P 500, Nasdaq 100, and Dow Jones Industrial Average are 22.1X, 25.0X, and 21.8X, indicating a narrowing of valuation levels compared to their historical highs [6] - The current return on equity (ROE) for the US stock market remains at 20%, higher than other developed markets, indicating limited alternatives for investment in global developed markets [7] Group 2: Short-term and Long-term Market Trends - Short-term volatility in the US stock market may increase due to profit-taking pressures in the technology sector and downward pressure on the retail sector from escalating trade tensions [8] - In the medium to long term, the combination of fiscal and monetary easing in the US is expected to sustain upward momentum in the stock market, with recommended focus areas including technology, manufacturing, energy infrastructure, military, and internet healthcare diagnostics [8] Group 3: Trade Relations and Economic Impact - The US government's linkage of Greenland's geopolitical claims to trade barriers has raised concerns about trade risks, with a proposed 10% tariff on goods from eight European countries, potentially increasing to 25% [2] - The economic structure of the eight European countries heavily relies on exports, which may lead to significant asymmetric impacts if trade barriers are implemented, potentially forcing some countries to compromise with the US [3] - The Danish pension fund's decision to sell its US Treasury holdings, although limited in scale, reflects growing concerns over credit risks associated with US policies, but is not expected to trigger significant liquidity risks in the US Treasury market [4]

Core Insights - The Douyin Giant Engine held a Manhua Ecological Conference in Hangzhou on January 20, highlighting the growing significance of the manhua market [1] - The peak daily consumption in the manhua sector reached 30 million, indicating strong user engagement and market potential [1] - The overall market size for manhua is projected to reach 22 billion by 2026, reflecting sustained high industry momentum [1] Content Analysis - From a content perspective, AI-generated dramas, high-quality IP adaptations, and innovative themes are showing higher hit rates, demonstrating the competitive advantage of quality content in the market [1] - On the technology front, AI technology has been deeply integrated into the manhua production pipeline, significantly reducing costs and increasing efficiency [1] - Leading AI dramas are enhancing their commercial value through copyright distribution and IAA+IAP co-investment strategies [1] Investment Recommendations - The AI drama industry is expected to maintain its favorable outlook, with a recommendation to focus on companies that possess quality IP and production capacity [1]

Core Insights - The National Healthcare Security Administration (NHSA) has released new guidelines for pricing related to surgical robots and surgical consumables, which is expected to accelerate the promotion and adoption of surgical robots in China [1] - The NHSA indicated that the guidelines will continue to expand in the future, benefiting the overall innovative medical device products [1] - CITIC Securities strongly recommends investors to focus on investment opportunities within the medical industry chain, particularly in the surgical robot sector and its upstream and downstream industries [1] Investment Focus Areas - Emphasis on the surgical robot industry and its related supply chain, including laparoscopic robots, orthopedic robots, and neurosurgical robots [1] - Recommendation to pay attention to high-value consumables in minimally invasive surgery, orthopedics, gastroenterology, cardiovascular, and neurology [1]

Core Viewpoint - Puxi Pharmaceuticals has submitted its listing application to the Hong Kong Stock Exchange, with CITIC Securities and Minyin Capital serving as joint sponsors [1] Company Overview - Puxi Pharmaceuticals focuses on the immuno-inflammatory field and has developed the world's first JAK inhibitor gel, Pumexitin Gel, for the treatment of atopic dermatitis, which has completed Phase III clinical trials for adults and adolescents aged 12 to 17, and is expanding to children aged 2 to 11 [1] - The company is also developing Pumexitin Nasal Spray, the world's first clinical-stage JAK inhibitor nasal spray for seasonal allergic rhinitis, currently in Phase III clinical trials for adults and expanding to adolescents and adults with perennial allergic rhinitis [1] - PG-033 tablets, a TRPV3 inhibitor with first-in-class potential for pruritus, are in Phase I clinical research, targeting stubborn pruritus related to Omstead syndrome and hyperkeratosis [1] - PG-018 tablets, a JAK1-ROCK dual-target inhibitor for autoimmune kidney disease, are also in Phase I clinical research [1] - PG-040 eye drops, a ROCK-JAK dual-target eye drop, are being developed as a new treatment option for glaucoma [1] Market Potential - The market for drugs treating autoimmune and allergic diseases is experiencing rapid growth both globally and in China [1] - The market for atopic dermatitis drugs in China is projected to grow from 11 billion RMB in 2024 to 50.2 billion RMB by 2033 [1]